fda warning letters compounding semaglutide october 2025 Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly Navigating Compounded Semaglutide: What Health

42 Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development Current and future development of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), or simply GLP-1s, involves complexities not only in formulation but in all areas of early-phase drug development

Understand the Mechanism: While many supplements claim to boost GLP-1, the mechanisms vary

The rate of weight loss also matters

If youre planning a pregnancy, all GLP-1 medications must be stopped 2 to 3 months before conception

Testing scope Whether third-party testing applies to the entire blended product , rather than only to individual peptide components